A Phase II Trial of Ipilimumab and Nivolumab for the Treatment of Rare Cancers
Clinical trial NCT02923934 · COMPLETED
Trial details
- NCT number
- NCT02923934
- Sponsor
- Olivia Newton-John Cancer Research Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-22
- Primary completion
- 2020-04-27
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.